000756 新华制药
已收盘 06-09 15:00:00
资讯
新帖
简况
新华制药（000756）披露获得碳酸司维拉姆干混悬剂药品注册证书公告，6月2日股价下跌0.88%
证券之星 · 06-02
新华制药（000756）披露获得碳酸司维拉姆干混悬剂药品注册证书公告，6月2日股价下跌0.88%
港股公告掘金 | 智谱拟发行A股并在科创板上市
智通财经 · 06-02
港股公告掘金 | 智谱拟发行A股并在科创板上市
新华制药：获批“碳酸司维拉姆干混悬剂”药品注册证书
财中社 · 06-01
新华制药：获批“碳酸司维拉姆干混悬剂”药品注册证书
新华制药（000756）披露2025年度周年股东会通知，5月26日股价下跌1.8%
证券之星 · 05-26
新华制药（000756）披露2025年度周年股东会通知，5月26日股价下跌1.8%
新华制药(000756.SZ)：苯巴比妥片通过仿制药一致性评价
智通财经 · 05-18
新华制药(000756.SZ)：苯巴比妥片通过仿制药一致性评价
股市必读：新华制药（000756）5月15日披露最新机构调研信息
证券之星 · 05-18
股市必读：新华制药（000756）5月15日披露最新机构调研信息
新华制药（000756）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.68%
证券之星 · 05-13
新华制药（000756）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.68%
新华制药：公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品
证券之星 · 05-13
新华制药：公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品
新华制药：氨溴特罗口服溶液获得药品注册证书
南方财经网 · 05-11
新华制药：氨溴特罗口服溶液获得药品注册证书
有生产汉坦病毒相关药品吗？新华制药：已布局并生产多款抗病毒产品
每日经济新闻 · 05-09
有生产汉坦病毒相关药品吗？新华制药：已布局并生产多款抗病毒产品
新华制药（000756）披露盐酸苄丝肼获化学原料药上市申请批准通知书，5月8日股价上涨0.28%
证券之星 · 05-08
新华制药（000756）披露盐酸苄丝肼获化学原料药上市申请批准通知书，5月8日股价上涨0.28%
新华制药一季度营收净利双降！经营现金流净额转负 股价较巅峰值跌超七成
深圳商报·读创 · 05-02
新华制药一季度营收净利双降！经营现金流净额转负 股价较巅峰值跌超七成
新华制药新提交“优迪加”等2件商标注册申请
证券之星 · 05-02
新华制药新提交“优迪加”等2件商标注册申请
图解新华制药一季报：第一季度单季净利润同比下降25.15%
证券之星 · 04-29
图解新华制药一季报：第一季度单季净利润同比下降25.15%
新华制药（000756）披露2025年度网上业绩说明会安排，4月27日股价下跌0.42%
证券之星 · 04-27
新华制药（000756）披露2025年度网上业绩说明会安排，4月27日股价下跌0.42%
智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨
智通财经 · 04-21
智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨
新华制药(000756.SZ)取得布美他尼注射液药品注册证书
智通财经 · 04-15
新华制药(000756.SZ)取得布美他尼注射液药品注册证书
新华制药：醋酸可的松滴眼液主要用于过敏性眼病
证券之星 · 04-09
新华制药：醋酸可的松滴眼液主要用于过敏性眼病
新华制药：有关治疗阿尔茨海默病的创新药OAB-14进展情况，请关注巨潮资讯网公司刊载的公告
证券之星 · 04-09
新华制药：有关治疗阿尔茨海默病的创新药OAB-14进展情况，请关注巨潮资讯网公司刊载的公告
新华制药获注射用浓钠钾镁钙溶液药品注册证书
美股速递 · 04-07
新华制药获注射用浓钠钾镁钙溶液药品注册证书
加载更多
公司概况
公司名称：
山东新华制药股份有限公司
所属行业：
医药制造业
上市日期：
1997-08-06
主营业务：
山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是解热镇痛类等原料药、片剂、针剂、胶囊剂等制剂、医药中间体及其他。
发行价格：
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":12.35,"timestamp":1780988628000,"preClose":12.48,"halted":0,"volume":3717634,"delay":0,"changeRate":-0.0104,"floatShares":499000000,"shares":697000000,"eps":0.3757,"marketStatus":"已收盘","change":-0.13,"latestTime":"06-09 15:00:00","open":12.48,"high":12.55,"low":12.22,"amount":45844500,"amplitude":0.0264,"askPrice":12.35,"askSize":85,"bidPrice":12.34,"bidSize":1111,"shortable":0,"etf":0,"ttmEps":0.3757,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781055000000},"marketStatusCode":5,"adr":0,"adjPreClose":12.48,"symbolType":"stock","openAndCloseTimeList":[[1780968600000,1780975800000],[1780981200000,1780988400000]],"highLimit":13.73,"lowLimit":11.23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":696683435,"isCdr":false,"pbRate":1.63,"roa":"--","peRate":32.871972,"roe":"1.59%","epsLYR":0.42,"committee":0.354894,"marketValue":8604000000,"turnoverRate":0.0075,"status":1,"hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":5.72,"timestamp":1780992493000,"preClose":5.78,"halted":0,"volume":836000,"delay":0,"premium":"-59.94"},"floatMarketCap":6161000000},"requestUrl":"/m/hq/s/000756","defaultTab":"news","newsList":[{"id":"2640914631","title":"新华制药（000756）披露获得碳酸司维拉姆干混悬剂药品注册证书公告，6月2日股价下跌0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914631?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:05","pubTimestamp":1780394735,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，新华制药报收于13.45元，较前一交易日下跌0.88%，最新总市值为93.7亿元。新华制药于近日披露《关于获得碳酸司维拉姆干混悬剂药品注册证书的公告》。公告显示，公司近日收到国家药品监督管理局核准签发的碳酸司维拉姆干混悬剂《药品注册证书》，药品注册分类为化学药品3类，规格为0.8g和2.4g，申请事项为境内生产药品注册。2025年中国公立医疗机构司维拉姆相关制剂销售额约为7.5亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995865","title":"港股公告掘金 | 智谱拟发行A股并在科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995865","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640995865?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:00","pubTimestamp":1780362051,"startTime":"0","endTime":"0","summary":"重大事项：丽珠医药：重组人促卵泡激素注射液获得《药品注册证书》山东新华制药股份：获得碳酸司维拉姆干混悬剂药品注册证书白云山：白云山制药总厂收到国家药监局核准签发的关于磷酸奥司他韦干混悬剂的《药品注册证书》智谱拟发行A股并在科创板上市驭势科技：与赛力斯凤凰智创完成行泊一体乘用车海外量产及交付澜起科技：横琴公司拟进行增资扩股并引入新投资方 引资合共约5亿元股东持续赋能!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999015952.SGD","BK1521","LU0865486749.SGD","BK1117","LU0683595622.HKD","BK1591","09868","GELYY","LU0819121731.USD","BK1594","LU1102505929.USD","LU0084288322.USD","LU0589944569.HKD","IE00B0JY6N72.USD","LU0516422952.EUR","LU0577902611.USD","LU0823426308.USD","IE00B5MMRT66.SGD","SG9999014674.SGD","LU0211977185.USD","BK1509","LU0871576103.HKD","LU0823426480.USD","LU0431992006.USD","LU2153592121.USD","LU2148510915.USD","BK1540","LU0326950275.SGD","LU0823414551.USD","LU0287142896.SGD","BK1604","LU2226246903.HKD","BK1587","LU0541502299.USD","688008","LU0501845795.SGD","LU0572944931.SGD","LU0181495838.USD","LU1719994722.HKD","SG9999001226.SGD","LU1770034418.SGD","LU0359201885.HKD","81211","SG9999015978.USD","LU2476274308.USD","09866","LU0605514214.HKD","82333","02886","LU0254981946.USD","LU0505663152.USD","LU2294711713.HKD","SG9999002463.SGD","LU1813983027.USD","LU2097828474.EUR","LU0052750758.USD","LU1102505762.USD","LU0449509016.USD","LU1282651048.USD","LU0828238088.HKD","LU2257852520.SGD","LU0823040885.USD","LU0259732245.USD","LU0577902454.USD","LU1242518857.USD","LU1152091168.USD","LU0593848301.USD","LU0594300179.USD","BK1589","LU0210526637.USD","LU0128522744.USD","LU0315178854.USD","SG9999002562.SGD","LU0823039010.USD","LU1226287529.USD","LU0543330483.HKD","LU1831875114.USD","SG9999015945.SGD","LU2125910500.SGD","000756","LU1880383440.USD","XPEV","LU0577902538.SGD","LU1282651121.HKD","LU0516422440.USD","LU1734074674.USD","LU0348825331.USD","LU0511384066.AUD","LU0499858438.USD","LU0359202008.SGD","LU0577902298.EUR","LU0611395673.USD","LU0540923850.HKD","LU0502904849.HKD","LU0823414478.USD","LU0345776255.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU0456846285.SGD","LU0878005551.USD","LU1688375341.USD","LU1861214812.USD","LU1861219969.SGD","IE00BF5LJ272.USD","LU0106252389.USD","LU0228659784.USD","LU0516423174.USD","LU1064130708.USD","LU1808992512.USD","LU1048596156.SGD","LU0261950983.USD","IE00B031HY20.USD","LU1152091754.HKD","LU0594300419.USD","601127","LU1868837565.USD","IE00BPRC5H50.USD","BK1197","LU0128522157.USD","80175","000513","00874","LU0029875118.USD","LU0039217434.USD","IE0008369823.USD","LU1868838027.USD","LU0509642566.USD","SG9999001689.USD","BYDDY","LU0823041008.USD","LU0979878070.USD","LU0320764755.SGD","IE0032431581.USD","METmain","LU2242644610.SGD","LU2360107325.USD","BK1142","LU0543330566.HKD","LU2097828631.EUR","LU1323998911.USD","LU0149721374.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","LU2399975544.HKD","IE0008368742.USD","SG9999006514.SGD","LU0244354667.USD","03690","LU0173614495.USD","LU0541501648.USD","LU0588545730.USD","LU0054237671.USD","LU0370786039.SGD","LU1251922891.USD","09927","LU0140636845.USD","LU0051755006.USD","LU1675838814.USD","SG9999001903.USD","LU0516422366.SGD","06809","GWLLY","LU0348788117.USD","LU1303224171.USD","LU1794554557.SGD","LU2087589342.USD","LU0856984785.SGD","LU0737861699.HKD","LU0918141705.HKD","LU0348814723.USD","LU1868837722.USD","LU2249611893.SGD","IE00BD6J9T35.USD","LU2778985437.USD","00175","LU0455707207.USD","LU0229945570.USD","LU0633140560.USD","LU1282648689.USD","LU0359201612.USD","LU2348774022.SGD","LU1023057109.AUD","LU0463099449.HKD","LU0417516902.SGD","LU2506951792.HKD","LU1242518931.SGD","IE00B29SXG58.USD","LU0868486357.SGD","LU0196878994.USD","IE0034224299.USD","LU0011963245.USD","LU1105468828.SGD","LU0672654166.SGD","HMTD.SI","LU2449936058.SGD","LU0449515922.USD","002594","BK1615","LU0320764599.SGD","LU1481107354.HKD","LU2097828805.USD","IE00B543WZ88.USD","LU1048588211.SGD","LU1961090484.USD","LU0634319403.HKD","HYDD.SI","LU0633140727.USD","BK1606","LU0289739343.SGD","LU2152927971.USD","LU0072913022.USD","LU0348735423.USD","LU0819123356.HKD","LU0417516738.SGD","LU0048580855.USD","LU0348827113.USD","LU1328615791.USD","LU0456827905.SGD","EVS.SI","SG9999000327.SGD","BK1582","LU0650527681.SGD","BK1588","LU0143863784.USD","BK1515","LU0048597586.USD","NIO","BK1163","BK1575","LU0214875030.USD","LU0164865239.USD","LU0708995583.HKD","00719","BK1583","LU1224444064.USD","BK1618","02513","LU0165289439.USD","LU0797268264.HKD","LU0164880469.USD","01513","BK1539","LU0588545490.SGD","600332","LU0821914370.USD","LU0231483743.USD","LU0049853897.USD","LU0588546209.SGD","LU0175139822.USD","NIO.SI","LU2476274720.SGD","LU0531971595.HKD","LU0700851271.USD","LU1188198961.HKD","LU1993786604.SGD","LU2045819591.USD","LU0348816934.USD","LU0269904917.USD","LU0251144936.SGD","LU0320764243.SGD","BK1221","BK1191","IE00B3M56506.USD","LU0314109678.HKD","LU0164872284.USD","601633","LU0043850808.USD","LU2357125470.USD","LU2488822045.USD","LU0348805143.USD","LU0315179316.USD","LU0918141887.USD","LU0577902371.SGD","LU2097828714.EUR","LU0047713382.USD","LU1720050803.USD","LU0345775950.USD","SG9999015986.USD","LU1328277881.USD","LU0307460666.USD","LU0828237940.HKD","LU1064131003.USD","LU0561508036.HKD","SG9999006597.SGD","LU0823038988.USD","LU0029874905.USD","SG9999000459.SGD","LU0499858602.USD","07489","LU0469268626.HKD","LU1008478684.HKD","LU0293314216.USD","02333","LU0289960550.SGD","BK1610","LU1880383366.USD","LU1224709979.USD","LU0828237510.HKD","LU1770036033.HKD","LU0067412154.USD","01511","BK1233","LU0117841782.USD","LU0880133367.SGD","BK1522","LU0132412106.USD","09973","LU0588545904.SGD","LU0531970944.HKD","01211","LU0708995153.HKD","LU0054450605.USD","LU0143863198.USD","LU0327786744.USD","MPNGY","LU2097828557.USD","SG9999002828.SGD","LU0072462343.USD","LU0873338254.USD","LU0289961442.SGD","BK1119","LU0516423091.SGD","LU2039709279.SGD","LU0326948709.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640627937","title":"新华制药：获批“碳酸司维拉姆干混悬剂”药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640627937","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640627937?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:08","pubTimestamp":1780304880,"startTime":"0","endTime":"0","summary":"6月1日，新华制药（000756/00719）发布公告，近日获得国家药品监督管理局核准签发的碳酸司维拉姆干混悬剂《药品注册证书》。该药品为处方药，规格为0.8g和2.4g，注册分类为化学药品3类。该药品主要用于控制正在接受透析治疗的慢性肾脏病成人患者的高磷血症，以及未进行透析的慢性肾脏病成人患者的高磷血症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013756095150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638554335","title":"新华制药（000756）披露2025年度周年股东会通知，5月26日股价下跌1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638554335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638554335?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:24","pubTimestamp":1779805465,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，新华制药报收于13.66元，较前一交易日下跌1.8%，最新总市值为95.17亿元。该股当日开盘13.93元，最高13.97元，最低13.57元，成交额达7249.83万元，换手率为1.06%。近日，山东新华制药股份有限公司披露《关于召开2025年度周年股东会的通知》。公告显示，公司将于2026年6月26日召开2025年度周年股东会，现场会议地点为山东省淄博市高新区鲁泰大道1号公司会议室。网络投票通过深圳证券交易所系统进行，股权登记日为2026年6月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636263730","title":"新华制药(000756.SZ)：苯巴比妥片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2636263730","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636263730?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:56","pubTimestamp":1779094607,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 新华制药(000756.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的苯巴比妥片(以下简称“本品”)《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。本品主要用于治疗焦虑、失眠(用于睡眠时间短早醒患者)、癫痫，是治疗癫痫大发作及部分性发作的药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636551015","title":"股市必读：新华制药（000756）5月15日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636551015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636551015?lang=zh_cn&edition=full","pubTime":"2026-05-18 02:39","pubTimestamp":1779043150,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，新华制药报收于14.29元，下跌1.18%，换手率1.28%，成交量6.38万手，成交额9185.8万元。来自：新华制药OB-14项目处于临床Ⅱa期，受试者入组已完成，公司正扎实推进研发进展。机构调研要点新华制药与鲁抗医药虽同属华鲁集团旗下的医药行业上市公司，但二者不存在实质性同业竞争问题。新华制药主要产品系解热镇痛类、心脑血管类及中枢神经类等药物；鲁抗医药主要产品包括抗生素原料药、制剂产品和兽用抗生素。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635733205","title":"新华制药（000756）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635733205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635733205?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:25","pubTimestamp":1778682318,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，新华制药报收于14.66元，较前一交易日下跌0.68%，最新总市值为102.13亿元。该股当日开盘14.75元，最高14.8元，最低14.63元，成交额达1.16亿元，换手率为1.58%。近日，新华制药发布《关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告》。公告显示，公司将于2026年5月15日15:00-16:30通过网络远程方式参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2026年山东辖区上市公司投资者网上集体接待日活动”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635920536","title":"新华制药：公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2635920536","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635920536?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:03","pubTimestamp":1778655793,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问：新华制药有预防或者治疗汉坦病毒的药物吗？新华制药回复：您好，公司是布洛芬等系列解热镇痛药物全球重要供应商，公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品及糖皮质激素系列、抗感染系列药物。具体以医生治疗方案为准。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300021629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634401641","title":"新华制药：氨溴特罗口服溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634401641","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634401641?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:49","pubTimestamp":1778489340,"startTime":"0","endTime":"0","summary":"南财智讯5月11日电，新华制药公告，公司收到国家药品监督管理局签发的氨溴特罗口服溶液《药品注册证书》。该产品用于治疗急、慢性呼吸道疾病（如急、慢性支气管炎、肺气肿等）引起的咳嗽、痰液黏稠、排痰困难、喘息等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733124867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634849785","title":"有生产汉坦病毒相关药品吗？新华制药：已布局并生产多款抗病毒产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2634849785","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634849785?lang=zh_cn&edition=full","pubTime":"2026-05-09 15:14","pubTimestamp":1778310877,"startTime":"0","endTime":"0","summary":"5月9日，新华制药召开业绩说明会，有投资者提问：新华制药有生产汉坦病毒相关药品吗？新华制药表示，新华制药已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品及糖皮质激素系列、抗感染药物系列。另外，新华制药一直是布洛芬等系列解热镇痛药物的生产基地。具体以医生治疗方案为准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605093732211626.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605093732211626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633445711","title":"新华制药（000756）披露盐酸苄丝肼获化学原料药上市申请批准通知书，5月8日股价上涨0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633445711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633445711?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:33","pubTimestamp":1778250791,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，新华制药报收于14.39元，较前一交易日上涨0.28%，最新总市值为100.25亿元。该股当日开盘14.34元，最高14.42元，最低14.28元，成交额达5058.35万元，换手率为0.71%。公司近日收到国家药品监督管理局核准签发的盐酸苄丝肼《化学原料药上市申请批准通知书》，审批结论为批准生产本品。本次获批有利于公司拓展新市场领域，提升竞争力。药品销售受政策、招标采购及市场环境等因素影响，存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800043813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632362468","title":"新华制药一季度营收净利双降！经营现金流净额转负 股价较巅峰值跌超七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2632362468","media":"深圳商报·读创","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632362468?lang=zh_cn&edition=full","pubTime":"2026-05-02 11:34","pubTimestamp":1777692889,"startTime":"0","endTime":"0","summary":"近日，新华制药（000756）披露2026年一季报，报告期内实现营收约24.23亿元，同比减少0.28%；归属于上市公司股东的净利润8390.30万元，同比减少25.15%。值得注意的是，一季度，新华制药经营活动产生的现金流量净额同比暴跌1483.38%至-1.17亿元。对此，新华制药称主要原因是公司本报告期为合理控制负债规模，优化负债结构，兑付的应付银行承兑汇票同比增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605023727543368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000756","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632625520","title":"新华制药新提交“优迪加”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632625520?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:56","pubTimestamp":1777676175,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日山东新华制药股份有限公司新提交“优迪加”等2件商标注册申请。商标申请详情如下：今年以来山东新华制药股份有限公司新申请注册商标2件，截止目前公司共持有注册商标753件，另有81件商标尚在注册申请中。通过天眼查大数据分析，山东新华制药股份有限公司共对外投资了19家企业，参与招投标项目14084次；财产线索方面有商标信息566条，专利信息590条；此外企业还拥有行政许可1070个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631307539","title":"图解新华制药一季报：第一季度单季净利润同比下降25.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631307539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631307539?lang=zh_cn&edition=full","pubTime":"2026-04-29 04:43","pubTimestamp":1777409038,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药2026年一季报显示，一季度公司主营收入24.23亿元，同比下降0.28%；归母净利润8390.3万元，同比下降25.15%；扣非净利润8029.17万元，同比下降23.55%；负债率38.3%，投资收益33.35万元，财务费用1479.26万元，毛利率18.2%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900010203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630390271","title":"新华制药（000756）披露2025年度网上业绩说明会安排，4月27日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630390271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630390271?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:20","pubTimestamp":1777299608,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，新华制药报收于14.27元，较前一交易日下跌0.42%，最新总市值为99.42亿元。近日，新华制药披露《关于举办2025年度网上业绩说明会的公告》。公告显示，公司已于2026年3月30日在巨潮资讯网披露《2025年年度报告》及摘要。为便于投资者了解公司经营业绩和发展战略，公司将于2026年5月9日9:00-10:00在“价值在线”举办2025年度网上业绩说明会，采用网络互动方式举行。公司现提前向投资者征集问题，截至2026年5月6日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700046307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629772986","title":"智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2629772986","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629772986?lang=zh_cn&edition=full","pubTime":"2026-04-21 07:28","pubTimestamp":1776727718,"startTime":"0","endTime":"0","summary":"根据2026年4月20日询价申购情况，初步确定的本次询价转让价格为410.34元/股。本次询价转让不通过集中竞价交易方式或大宗交易方式进行，不属于通过二级市场减持。受让方通过询价转让受让的股份，在受让后6个月内不得转让。截至收盘，暗盘交易显示报价333港元，较招股价209.88港元上涨58.66%，每手100股，不计手续费，每手赚12312港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bd99c7d8869305150ea2122170bfd90e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997244956.HKD","LU2039709279.SGD","IE00B8L5B284.USD","LU2249611893.SGD","IE00B3M56506.USD","LU0106959298.USD","LU0231483743.USD","LU1226287875.USD","00451","BK1521","LU0072913022.USD","LU1719994722.HKD","LU2097828631.EUR","LU0302445910.USD","LU2298321311.HKD","LU0214875030.USD","HK0000181112.HKD","LU1721428347.USD","LU1808992512.USD","LU1039395188.USD","LU1951186391.HKD","603093","IE0003795394.USD","LU0449515922.USD","LU1102505929.USD","03983","LU0054450605.USD","LU0543330483.HKD","LU2298322129.HKD","SG9999002828.SGD","LU0251143458.SGD","LU0516423174.USD","LU0254981946.USD","LU1880383440.USD","LU0405327148.USD","LU2153591404.USD","02691","02476","SGXZ81163826.USD","LU1979443071.USD","01866","IE00BZ08YS42.EUR","LU0164865239.USD","LU1655091616.SGD","LU2125910849.SGD","LU2097828805.USD","IE0032431581.USD","LU0049853897.USD","LU0039217434.USD","LU1794554557.SGD","LU2328871848.SGD","SHPMY","LU2153592121.USD","BK1129","LU2506952337.HKD","LU0823414551.USD","BK4585","00719","LU2097828557.USD","LU1152091168.USD","LU1580142542.USD","LU0149534421.HKD","LU2477742899.HKD","LU0607220059.USD","LU0261950470.USD","LU0314109678.HKD","IE0008369823.USD","LU0269904917.USD","LU1023057109.AUD","LU0516422440.USD","LU0011963245.USD","03750","BK4526","LU1813983027.USD","BK4588","LU0128522157.USD","LU0312595415.SGD","LU3063872942.SGD","LU0235996351.USD","LU2097828474.EUR","LU0188438112.USD","002466","LU2778985437.USD","LU0370786039.SGD","LU2360108059.USD","LU0593848301.USD","LU1048596156.SGD","LU1861214812.USD","CBLUY","LU0405327494.USD","LU1939255532.USD","META","BK4141","LU2298064838.USD","HK0000165453.HKD","LU0979878070.USD","LU1969619763.USD","LU2449936058.SGD","LU2506952410.USD","LU0651946864.USD","LU0048388663.USD","02607","IE0003851619.USD","LU0228659784.USD","SG9999000459.SGD","LU0516422366.SGD","LU0029875118.USD","LU0605514214.HKD","BK1594","LU0320764755.SGD","LU1303224171.USD","LU1861219969.SGD","LU1934453819.USD","LU0165289439.USD","LU0594300179.USD","BK4519","LU0181495838.USD","LU0828237940.HKD","LU2289578879.USD","LU0259732245.USD","LU0502904849.HKD","LU1328277881.USD","LU1048588211.SGD","LU0821914370.USD","LU0823414478.USD","LU1051768304.USD","LU1868837565.USD","LU1820825898.SGD","LU0048580855.USD","LU2045819591.USD","LU0072462343.USD","01093","00297","LU0823437842.USD","LU2476274720.SGD","LU0359201612.USD","LU1961090484.USD","LU0871576103.HKD","IE00BPRC5H50.USD","IE00BZ08YR35.GBP","LU0315179316.USD","LU0505663152.USD","300476","LU0326948709.USD","BK0224","LU0828237510.HKD","LU2238339852.HKD","SGXZ49509284.SGD","SG9999002463.SGD","LU2394011477.USD","LU0828238088.HKD","LU1960683339.HKD","IE00B031HY20.USD","02575","LU0244354667.USD","LU2125910500.SGD","LU1226287529.USD","04335","LU0326950275.SGD","LU1251922891.USD","EVS.SI","LU1997245094.SGD","LU2506952253.HKD","LU1880383366.USD","LU0572944931.SGD","LU0132412106.USD","HK0000181138.USD","SG9999000327.SGD","LU1242518857.USD","LU0043850808.USD","LU2506951792.HKD","SG9999001689.USD","LU0051755006.USD","LU0611395673.USD","LU1978683503.SGD","COIN","LU0328353924.USD","LU0823426308.USD","LU1102505762.USD","03393","LU0067412154.USD","LU0048575426.USD","LU0449509016.USD","BK1191","LU0106252389.USD","LU1770034418.SGD","LU1993786604.SGD","SG9999001903.USD","LU0359201885.HKD","LU0456827905.SGD","03200","LU0509642566.USD","LU0192582467.USD","LU0724618433.USD","LU1226287792.SGD","TSLA","LU1051769294.HKD","LU2097828714.EUR","SG9999003461.SGD","LU2580892862.HKD","LU1769817096.USD","000756","LU1515016050.SGD","LU0047713382.USD","SNFRY","LU2360107325.USD","LU0327786744.USD","LU0107464264.USD","LU2152927971.USD","300750","IE00B5MMRT66.SGD","LU0516422952.EUR","LU0501845795.SGD","IE0008368742.USD","LU2242644610.SGD","BK1554","LU0672654166.SGD","LU0880133367.SGD","BK1116","09696","LU0516423091.SGD","LU1868838027.USD","LU1146622755.USD","LU1831875114.USD","LU0650527681.SGD","SG9999004220.SGD","BK1515","LU2348774022.SGD","LU1997245177.USD","601607","IE00B543WZ88.USD","BK1147","LU0455707207.USD","LU0531971595.HKD","LU1781817850.SGD","LU2399975544.HKD","INTC","LU1064130708.USD","LU2424517915.HKD","SG9999001846.SGD","PLUG","LU1769817179.HKD","LU1226288170.HKD","BK1610","LU2275660780.HKD","LU0823426480.USD","600941","LU0143863198.USD","LU0124384867.USD","LU2495084118.USD","LU0348805143.USD","LU0140636845.USD","LU2148510915.USD","301200","LU0106259558.USD","LU0594300419.USD","LU0210526637.USD","BK1154","LU1242518931.SGD","LU2348773727.SGD","IE00B29SXG58.USD","IE00BZ199S13.USD","LU2092937221.SGD","LU2041044095.USD","LU2476274308.USD","LU1064131003.USD","LU1807302812.USD","LU0359202008.SGD","LU2294711473.HKD","LU0463099449.HKD","LU0143863784.USD","00941","LU0651947912.USD","IE00B8HQ1Z84.USD","LU1255011170.USD","LU0469268626.HKD","LU0531970944.HKD","IE00BD6J9T35.USD","IE00BZ08YT58.USD","LU1188198961.HKD","LU2580892789.USD","06608","LU2294711713.HKD","LU1008478684.HKD","LU2357125470.USD","LU1226288253.USD","SG9999014674.SGD","LU1152091754.HKD","LU1720050803.USD","LU0164872284.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627402263","title":"新华制药(000756.SZ)取得布美他尼注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2627402263","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627402263?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:50","pubTimestamp":1776243047,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药 公告，公司收到国家药品监督管理局核准签发的布美他尼注射液《药品注册证书》。在高血压的梯度疗法中，不作为治疗原发性高血压的首选药物，但当噻嗪类药物疗效不佳，尤其当伴有肾功能不全或出现高血压危象时，本类药物尤为适用。抗利尿激素分泌过多症。急性药物毒物中毒等的治疗，如巴比妥类药物中毒等。对某些呋塞米无效的病例仍可能有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新华制药(000756.SZ)取得布美他尼注射液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626298902","title":"新华制药：醋酸可的松滴眼液主要用于过敏性眼病","url":"https://stock-news.laohu8.com/highlight/detail?id=2626298902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626298902?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:33","pubTimestamp":1775723589,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药04月09日在投资者关系平台上答复投资者关心的问题。醋酸可的松滴眼液主要用于过敏性眼病，属于糖皮质激素类眼药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900026018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626902334","title":"新华制药：有关治疗阿尔茨海默病的创新药OAB-14进展情况，请关注巨潮资讯网公司刊载的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902334","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626902334?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:12","pubTimestamp":1775722325,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好：新华制药研发用于治疗阿尔茨海默病的创新药OAB-14，之前公告已经进入二期临床实验了，距离上次公示已经一年了，这款药物进展如何了，是不是今年能上市？巨潮资讯网是公司指定信息披露媒体，有关治疗阿尔茨海默病的创新药OAB-14进展情况，请关注巨潮资讯网公司刊载的公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900024773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","BK0164","06978","BK1574","159992","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133210206","title":"新华制药获注射用浓钠钾镁钙溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1133210206","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133210206?lang=zh_cn&edition=full","pubTime":"2026-04-07 18:38","pubTimestamp":1775558308,"startTime":"0","endTime":"0","summary":"新华制药近日成功获得国家药品监督管理局核准签发的注射用浓钠钾镁钙溶液药品注册证书。这一重要进展标志着该公司在电解质补充剂领域的产品线得到进一步拓展与强化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781043448311,"stockEarnings":[{"period":"1week","weight":-0.0818},{"period":"1month","weight":-0.1418},{"period":"3month","weight":-0.1981},{"period":"6month","weight":-0.2362},{"period":"1year","weight":-0.2004},{"period":"ytd","weight":-0.1986}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0407},{"period":"3month","weight":-0.0299},{"period":"6month","weight":0.0353},{"period":"1year","weight":0.1795},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"1997-08-06","address":"山东省淄博市张店区高新技术产业开发区化工区","registeredCapital":"69668万元","survey":" 山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是解热镇痛类等原料药、片剂、针剂、胶囊剂等制剂、医药中间体及其他。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}